Literature DB >> 16672235

The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1.

Jeyanthy Eswaran1, Judit E Debreczeni, Emma Longman, Alastair J Barr, Stefan Knapp.   

Abstract

The receptor-type protein tyrosine phosphatases (RPTPs) are integral membrane proteins composed of extracellular adhesion molecule-like domains, a single transmembrane domain, and a cytoplasmic domain. The cytoplasmic domain consists of tandem PTP domains, of which the D1 domain is enzymatically active. RPTPkappa is a member of the R2A/IIb subfamily of RPTPs along with RPTPmu, RPTPrho, and RPTPlambda. Here, we have determined the crystal structure of catalytically active, monomeric D1 domain of RPTPkappa at 1.9 A. Structural comparison with other PTP family members indicates an overall classical PTP architecture of twisted mixed beta-sheets flanked by alpha-helices, in which the catalytically important WPD loop is in an unhindered open conformation. Though the residues forming the dimeric interface in the RPTPmu structure are all conserved, they are not involved in the protein-protein interaction in RPTPkappa. The N-terminal beta-strand, formed by betax association with betay, is conserved only in RPTPs but not in cytosolic PTPs, and this feature is conserved in the RPTPkappa structure forming a beta-strand. Analytical ultracentrifugation studies show that the presence of reducing agents and higher ionic strength are necessary to maintain RPTPkappa as a monomer. In this family the crystal structure of catalytically active RPTPmu D1 was solved as a dimer, but the dimerization was proposed to be a consequence of crystallization since the protein was monomeric in solution. In agreement, we show that RPTPkappa is monomeric in solution and crystal structure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672235      PMCID: PMC2242534          DOI: 10.1110/ps.062128706

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  25 in total

Review 1.  Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Authors:  J N Andersen; O H Mortensen; G H Peters; P G Drake; L F Iversen; O H Olsen; P G Jansen; H S Andersen; N K Tonks; N P Møller
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Residue 259 is a key determinant of substrate specificity of protein-tyrosine phosphatases 1B and alpha.

Authors:  G H Peters; L F Iversen; S Branner; H S Andersen; S B Mortensen; O H Olsen; K B Moller; N P Moller
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

3.  Cloning and characterization of R-PTP-kappa, a new member of the receptor protein tyrosine phosphatase family with a proteolytically cleaved cellular adhesion molecule-like extracellular region.

Authors:  Y P Jiang; H Wang; P D'Eustachio; J M Musacchio; J Schlessinger; J Sap
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

4.  Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases.

Authors:  L F Iversen; H S Andersen; K B Møller; O H Olsen; G H Peters; S Branner; S B Mortensen; T K Hansen; J Lau; Y Ge; D D Holsworth; M J Newman; N P Hundahl Møller
Journal:  Biochemistry       Date:  2001-12-11       Impact factor: 3.162

5.  Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface.

Authors:  G Jiang; J den Hertog; T Hunter
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

Authors:  P Schuck
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

7.  Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.

Authors:  Luisa Novellino; Nicolina Renkvist; Francesca Rini; Arabella Mazzocchi; Licia Rivoltini; Angela Greco; Paola Deho; Paola Squarcina; Paul F Robbins; Giorgio Parmiani; Chiara Castelli
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

8.  Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas.

Authors:  Mitsutoshi Nakamura; Munehiro Kishi; Toshisuke Sakaki; Hiroyuki Hashimoto; Hiroyuki Nakase; Keiji Shimada; Eiwa Ishida; Noboru Konishi
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

9.  Ligand-mediated negative regulation of a chimeric transmembrane receptor tyrosine phosphatase.

Authors:  D M Desai; J Sap; J Schlessinger; A Weiss
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

Review 10.  Protein tyrosine phosphatases in the human genome.

Authors:  Andres Alonso; Joanna Sasin; Nunzio Bottini; Ilan Friedberg; Iddo Friedberg; Andrei Osterman; Adam Godzik; Tony Hunter; Jack Dixon; Tomas Mustelin
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

View more
  6 in total

1.  The homophilic receptor PTPRK selectively dephosphorylates multiple junctional regulators to promote cell-cell adhesion.

Authors:  Gareth W Fearnley; Katherine A Young; James R Edgar; Robin Antrobus; Iain M Hay; Wei-Ching Liang; Nadia Martinez-Martin; WeiYu Lin; Janet E Deane; Hayley J Sharpe
Journal:  Elife       Date:  2019-03-29       Impact factor: 8.140

2.  Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases.

Authors:  Cynthia M Chio; Xiaoling Yu; Anthony C Bishop
Journal:  Bioorg Med Chem       Date:  2015-03-17       Impact factor: 3.641

3.  The lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cells.

Authors:  Nuria Sánchez-Morgan; Kathrin H Kirsch; Philip C Trackman; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2011-06-20       Impact factor: 4.272

4.  Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and Fyn.

Authors:  So-Hee Lim; Seok-Kyu Kwon; Myung Kyu Lee; Jeonghee Moon; Dae Gwin Jeong; Eunha Park; Seung Jun Kim; Byung Chul Park; Sang Chul Lee; Seong-Eon Ryu; Dae-Yeul Yu; Bong Hyun Chung; Eunjoon Kim; Pyung-Keun Myung; Jae-Ran Lee
Journal:  EMBO J       Date:  2009-10-08       Impact factor: 11.598

5.  The receptor PTPRU is a redox sensitive pseudophosphatase.

Authors:  Iain M Hay; Gareth W Fearnley; Pablo Rios; Maja Köhn; Hayley J Sharpe; Janet E Deane
Journal:  Nat Commun       Date:  2020-06-26       Impact factor: 14.919

6.  Chemical activation of divergent protein tyrosine phosphatase domains with cyanine-based biarsenicals.

Authors:  Bailey A Plaman; Wai Cheung Chan; Anthony C Bishop
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.